Skip to main content

Plans to access new Velindre Cancer Centre

Plans have been published for access roads to the new Velindre Cancer Centre.

Serving the whole of South East Wales, the new centre is due to open in 2024. It will have the capacity for 8,500 new patients and 160,000 patient appointments a year – up from the current levels by two thousand and 20,000.

TCS General map small

Draft plans cover new road and car parking layouts at the Asda store in Coryton where the main access to the new Velindre Cancer Centre will be. They are available for comment by Sunday 22 March. Velindre University NHS Trust and Asda will then submit a joint planning application for Cardiff City Council to determine.

The Trust is also seeking to extend the period when the temporary construction road on the Whitchurch Hospital site can be used.  We want to use the road both for construction of access to the new centre and for construction of the centre itself. As a result Velindre can reduce costs and bring forward the opening date.

Speaking of the main entrance at Asda, Velindre Project Director David Powell said: “The access will be more convenient for the majority of patients and staff who travel to the cancer centre from across South East Wales, not just Cardiff.

“It will also substantially reduce the traffic congestion caused by people driving through Whitchurch to the existing cancer centre.”

Referring to the planning application for the temporary construction access road on the Whitchurch Hospital site, David said: “The extension in time will help us open the new Velindre Cancer Centre ten months earlier, in 2024. It will also save up to £11.5 million of public money.”

In the spring of 2018 Cardiff City Council granted planning permission for the new centre with a main access from the Asda site, an emergency access from Hollybush Road and temporary construction access through the old Whitchurch Hospital site and Lady Cory Field.

You can view the plans at The Urbanists website.

For further information about how to find out more and how to comment, please go this web page.